What Divides Patients and Providers on GLP-1 Adherence
With the emergence of GLP-1s, there is a divide between patient perception of the medication and how clinical science views it. Find out more with Omada.
Read Article
With the emergence of GLP-1s, there is a divide between patient perception of the medication and how clinical science views it. Find out more with Omada.
Read Article
A side-effect of taking GLP-1s is a loss of muscle mass. Julie Mulcahy, PT, DPT, CAPP OB explores how to combat this with resistance exercises.
Read Article
Omada Health, the virtual-first healthcare provider, published its 28th peer-reviewed study demonstrating the long-term outcomes of utilizing a behavior change program for members with type 2 diabetes
Read Article
Join Omada in observing Diabetes Alert Day on March 22, 2024 as we cover the statistics of diabetes and some of the risk factors to watch out for.
Read Article
Lisa McCormick, FNP-BC, RD, CDCES explores the science behind dieting and why it doesn't work. Find out more about sustainable weight loss!
Read Article
Findings show that meaningfully engaged Omada members on GLP-1s achieved an average of 1.7 times greater weight loss, and inform a new collaboration with Evernorth's EncircleRx program.
Read Article
Obesity is now widely recognized as a lifelong chronic disease–but what’s behind that evolution? Join us to find out!
Read Article
Leading Innovation at NEBGH 13th Annual Health and Wellness Benefits Conference
Read Article
Join Us at HLTH 2024 in Las Vegas!
Read Article
Pioneering Transformation at AHIP 2024 Consumer Experience and Digital Health Forum
Read Article
Omada Health: Shining as a Gold Level Sponsor at AHIP 2024!
Read Article
Charting New Frontiers at the Lockton People Solutions Conference 2024
Read Article
A proud Gold Sponsor of the 2024 Thrive experience! Join our leaders, Tom Maraday and Kevin Masci on Thursday, April 11!
Read Article
Building on more than a decade of insights and 28 peer-reviewed publications, Omada announces plans to develop more learnings focused on the long-term outcomes of GLP-1s on weight health
Read Article
Omada delivers GLP-1 FAQs focusing on weight loss quantity vs. quality with timely data and insights for employers, health plans and benefit consultants.
Read Article
With more than eight in 10 U.S. adults now using digital health tools it is more important than ever for us to ensure that health data is secure.
Read Article
Omada Health Enhances GLP-1 Care Track to Support Customers Managing Medications and Integrates MSK Support.
Read Article
The purpose of this study is to examine the long-term impact of a digital diabetes self-management education and support (DSMES) program on A1C among adults with type 2 diabetes (T2DM).
Read Article
Obesity is one of the clearest case studies of health disparities that exist in the U.S., having the biggest impact on Black and Hispanic adults, low-income populations, and people covered by Medicaid
Read Article
GLP-1 agonist medications have had impressive initial outcomes. However, the long-term effects on a patient’s health beyond the trial timelines and on the costs to the healthcare system are uncertain.
Read Article
Loading More...